Biotech companies worldwide reported a profit in 2009 for the first time since 1985 as revenues increased and spending on R&D was cut.
A report published yesterday by Ernst and Young Global Ltdrevealed that the industry had made a profit of $3.7 billion, compared with a loss of $1.8 billion in 2008 in the U.S, Europe, Canada and Australia.
EuropaBio, the European Association for Bioindustries, and Venture Valuation, with the collaboration of
national stakeholders, yesterday published a ground-breaking report “Biotech in the new EU Member
States: an emerging sector”...